Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

European stocks rise on German debt deal hopes; AstraZeneca in focus By Investing.com

European stocks rise on German debt deal hopes; AstraZeneca in focus…

AstraZeneca to acquire EsoBiotec advance cell therapy platform

AstraZeneca has announced an agreement to acquire EsoBiotec, securing the biotechnology firm’s pioneering in vivo cell therapy platform that has…

AstraZeneca to buy EsoBiotec for up to $1 billion

Drugmaker AstraZeneca said on Monday it will buy biotechnology firm EsoBiotec for up to $1 billion.…

Prediction: This Vanguard Index Fund Will Continue to Beat the S&P 500 in 2025

The Trump administration has unnerved investors with its departure from traditional trade policy. The average tax on U.S. imports fell…

AstraZeneca Aktie: Performance überzeugt erneut

AstraZeneca befindet sich an einem entscheidenden Punkt, während die Pharmamärkte mit sich entwickelnden wirtschaftlichen Belastungen und veränderter Anlegerstimmung konfrontiert sind.…

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know

In the latest trading session, Astrazeneca (AZN) closed at $75.57, marking a +1.79% move from the previous day.…

UBS stuft ASTRAZENECA auf Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Astrazeneca auf "Buy" mit einem Kursziel von 14200…

Director/PDMR Shareholding

7 March 2025 Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 6 March 2025, an award of…

AstraZeneca’s Imfinzi success a step towards $80bn revenue aim

AstraZeneca PLC has edged closer to its aim of generating $80 billion in revenue come 2030 on positive results from…

dpa-AFX ProFeed